fbpx
Size of letters 1x
Site color
Image
Additionally
Line height
Letter spacing
Font
Embedded items (videos, maps, etc.)
 

Ukraine approves 2026 quotas for controlled substances, including medical cannabis (Thc)

26/ 01/ 2026
  On 29 December 2025, Ukraine adopted Resolution No. 1772, approving quotas for 2026 on the cultivation of plants containing narcotic and psychotropic substances, as well as the production, manufacturing, storage, import, and export of such substances. This includes tetrahydrocannabinol (THC), including ∆9 THC, marking an important milestone for the medical cannabis sector. For the first time, quotas have been set for substances based on medical cannabis. These quotas cover: Import for scientific and technical purposes; Import for the manufacturing of active pharmaceutical ingredients (API) and medicinal products; Medicinal products and APIs authorised in Ukraine for compounding or customising in a pharmacy. The approved quota for THC (including ∆9 THC) is as follows: Production: 493,535 grams; Import: 592,168 grams; Export: 100 grams; Storage: 592,068 grams. This decision reflects Ukraine’s commitment to ensuring compliance with international conventions while maintaining strict control over the legal circulation these products. Legal basis and why quotas are essential Under the Law on Narcotic Drugs, Psychotropic Substances and Precursors, quotas represent the maximum quantity of narcotic drugs and psychotropic substances based on the calculated national need for circulation over a defined period. Article 14 of the Law requires the Cabinet of Ministers to annually determine quotas for narcotic drugs and psychotropic substances, including cultivation of plants containing these substances, and for their production, manufacturing, storage, import, and export. These quotas are a mandatory control measure under Ukrainian law and international treaties that ensure: Application of restrictions and prohibitions on circulation of certain substances; Issuance of permits for import/export by the State Service of Ukraine on Medicines and Drug Control strictly within the quota limits; Compliance with UN Conventions Quotas are a legal prerequisite for any lawful activity involving controlled substances in Ukraine. They define the national ceiling for production and trade, directly impacting licensing, supply planning, and compliance obligations for businesses operating in the medical cannabis sector. For more information on quotas for narcotics and psychotropic substances, contact your CMS client partner or the CMS expert: Borys Danevych.

On 29 December 2025, Ukraine adopted Resolution No. 1772, approving quotas for 2026 on the cultivation of plants containing narcotic and psychotropic substances, as well as the production, manufacturing, storage, import, and export of such substances. This includes tetrahydrocannabinol (THC), including ∆9 THC, marking an important milestone for the medical cannabis sector.

For the first time, quotas have been set for substances based on medical cannabis. These quotas cover:

  • Import for scientific and technical purposes;
  • Import for the manufacturing of active pharmaceutical ingredients (API) and medicinal products;
  • Medicinal products and APIs authorised in Ukraine for compounding or customising in a pharmacy.

The approved quota for THC (including ∆9 THC) is as follows:

  • Production: 493,535 grams;
  • Import: 592,168 grams;
  • Export: 100 grams;
  • Storage: 592,068 grams.

This decision reflects Ukraine’s commitment to ensuring compliance with international conventions while maintaining strict control over the legal circulation these products.

Legal basis and why quotas are essential

Under the Law on Narcotic Drugs, Psychotropic Substances and Precursors, quotas represent the maximum quantity of narcotic drugs and psychotropic substances based on the calculated national need for circulation over a defined period.

Article 14 of the Law requires the Cabinet of Ministers to annually determine quotas for narcotic drugs and psychotropic substances, including cultivation of plants containing these substances, and for their production, manufacturing, storage, import, and export. These quotas are a mandatory control measure under Ukrainian law and international treaties that ensure:

  • Application of restrictions and prohibitions on circulation of certain substances;
  • Issuance of permits for import/export by the State Service of Ukraine on Medicines and Drug Control strictly within the quota limits;

Compliance with UN Conventions

Quotas are a legal prerequisite for any lawful activity involving controlled substances in Ukraine. They define the national ceiling for production and trade, directly impacting licensing, supply planning, and compliance obligations for businesses operating in the medical cannabis sector.

For more information on quotas for narcotics and psychotropic substances, contact your CMS client partner or the CMS expert: Borys Danevych.

This material is provided by a member company or partner organization of the European Business Association as part of an informational collaboration. The Association is not responsible for the accuracy, completeness, or reliability of the information presented. The views, opinions, and recommendations expressed in this material are solely those of the authors and do not reflect the official position of the European Business Association.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Start
in the Telegram bot
Read articles. Share in social networks
Nationwide Minute of Silence
01:00
09:00
Nationwide Minute of Silence
Let us honor the memory of all those who lost their lives in russia’s war against Ukraine
00:43

Spelling error report

The following text will be sent to our editors: